30629375|t|[Neurology].
30629375|a|Thrombolysis and late thrombectomy can be performed in case of compatible radiological imaging. Anti-CGRP monoclonal antibodies seem more effective for the treatment of migraine. Siponimod can reduce significantly disability progression in secondarily progressive MS. Brand-to-generic levetiracetam switching does not cause recrudescence of epileptic seizures. A new definition of Alzheimer's disease using biomarkers of cerebrospinal fluid (CSF) and imaging provides a better understanding of the underlying mechanisms. The use of levodopa-carbidopa intestinal gel and a subcutaneous apomorphine infusion allow a reduction of motor fluctuations in Parkinson's disease. Eculizumab appears as an alternative treatment in severe forms of myasthenia gravis.
30629375	13	25	Thrombolysis	Disease	
30629375	114	118	CGRP	Gene	796
30629375	182	190	migraine	Disease	MESH:D008881
30629375	192	201	Siponimod	Chemical	MESH:C578989
30629375	227	237	disability	Disease	MESH:D009069
30629375	277	279	MS	Disease	MESH:D009103
30629375	298	311	levetiracetam	Chemical	MESH:D000077287
30629375	354	372	epileptic seizures	Disease	MESH:D004827
30629375	394	413	Alzheimer's disease	Disease	MESH:D000544
30629375	545	563	levodopa-carbidopa	Chemical	MESH:C009265
30629375	598	609	apomorphine	Chemical	MESH:D001058
30629375	662	681	Parkinson's disease	Disease	MESH:D010300
30629375	683	693	Eculizumab	Chemical	MESH:C481642
30629375	749	766	myasthenia gravis	Disease	MESH:D009157
30629375	Negative_Correlation	MESH:C578989	MESH:D009103
30629375	Negative_Correlation	MESH:C009265	MESH:D010300
30629375	Association	MESH:D008881	796
30629375	Negative_Correlation	MESH:C481642	MESH:D009157
30629375	Negative_Correlation	MESH:D001058	MESH:D010300
30629375	Negative_Correlation	MESH:C578989	MESH:D009069

